*Department of Veterans Affairs Medical Center, White River Junction, VT

†Yale School of Medicine, New Haven, CT

‡Geisel School of Medicine at Dartmouth, Hanover, NH

§Yale School of Public Health, New Haven, CT

∥Department of Veterans Affairs Connecticut Healthcare System, West Haven, CT

¶London School of Hygiene and Tropical Medicine, London, England

#Department of Veterans Affairs Medical Center

**Stanford School of Medicine, Palo Alto, CA

††Department of Emergency Medicine, University of California, San Francisco, CA

This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, The Disrupted Care National Project, Award C19 21-287, PI: Davies.

C.K. has been an investigator on projects with research grants from Pfizer and Sanofi Pasteur for work unrelated to this manuscript. A.J.P. is or has been the principal investigator on research grants from Bayer, Boehringer-Ingelheim, Lundbeck, Reata, and Vascular Dynamics to Yale University for work unrelated to this manuscript; has received honoraria for data safety monitoring activities from Ablative Solutions and KBP Biosciences; and has received consulting fees from BD, CinCor, and Diamedica, all for work unrelated to this manuscript. D.M.W. has received consulting fees for work unrelated to this manuscript from Pfizer, Merck, GSK, Affinivax, and Matrivax, and is the Principal Investigator on research grants from Pfizer and Merck to Yale University for work unrelated to this manuscript. The remaining authors declare no conflict of interest.

Correspondence to: Caroline Korves, ScD, Veterans Affairs Medical Center, 215 North Main Street, White River Junction, VT 05009. E-mail: [email protected].

Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal’s website, www.lww-medicalcare.com.